Shares of Labcorp Holdings Inc. LH slid 2.16% to $277.74 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.28% to 7,482.71 ...

Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...

Danaher Corporation’s DHR Biotechnology segment continues to be a major contributor to its growth. In the first quarter of ...

Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Patients who get blood work through Labcorp can now receive AI-generated plain-language explanations of their results inside ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.

Shares of Labcorp Holdings Inc. LH rallied 1.39% to $283.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 7,483 ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...